Yanqi Liu

机构：Harbin Medical University, Yunnan Agricultural University, Fourth Affiliated Hospital of Harbin Medical University, First Affiliated Hospital of Harbin Medical University · ORCID：0000-0002-1922-6929

发表论文 130 篇 · 总被引 3513 次 · h-index 30

代表论文

• Metabolomics- and proteomics-based multi-omics integration reveals early metabolite alterations in sepsis-associated acute kidney injury (2025 · BMC Medicine · 被引 43)
• Sivelestat sodium protects against renal ischemia/reperfusion injury by reduction of NETs formation (2025 · Archives of Biochemistry and Biophysics · 被引 17)
• A prognostic glycolysis-related gene signature in osteosarcoma: implications for metabolic programming, immune microenvironment, and drug response (2025 · PeerJ · 被引 5)
• SAA1 as a Potential Early Diagnostic Biomarker for Sepsis Through Integrated Proteomics and Metabolomics (2025 · Immunology · 被引 4)
• Resveratrol as a BCL6 natural inhibitor suppresses germinal center derived Non-Hodgkin lymphoma cells growth (2025 · Journal of Natural Medicines · 被引 4)
• Identification of Mitochondrial-related Characteristic Biomarkers inOsteosarcoma using Bioinformatics and Machine Learning (2025 · Combinatorial Chemistry & High Throughput Screening · 被引 3)